Progenics Pharma (PGNX) Tops Q2 Views; Revs Heavy
Tweet
Share
E-mailGet Alerts PGNX Hot Sheet
Price: $4.10 --0%
Financial Fact:
General and administrative: 7.22M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
General and administrative: 7.22M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Progenics Pharma (NASDAQ: PGNX) reported Q2 EPS of $1.64, versus the analyst estimate of ($0.25). Revenue for the quarter came in at $74.41 million versus the consensus estimate of $9.98 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- Smith-Midland Corporation (SMID) Tops Q2 EPS by 26c
- Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
